7YR企业会员
| 英文名称 | 中文名称 | CAS |
|---|---|---|
| (Z)-JIB-04 | 199596-24-2 | |
| Ispinesib | 336113-53-2 | |
| Selumetinib | 606143-52-6 | |
| SM-164 | 957135-43-2 | |
| Nutlin-3b | 675576-97-3 | |
| Nutlin-3 | 548472-68-0 | |
| AT-406 | 1071992-99-8 | |
| ML324 | 1222800-79-4 | |
| KW-2449 | 1000669-72-6 | |
| UNC-2025 | 1429881-91-3 | |
| SU 5614 | 1055412-47-9 | |
| NCGC00244536 | 2003260-55-5 | |
| GDC-0084 | 1382979-44-3 | |
| GSK1059615 | 958852-01-2 | |
| CC-223 | 1228013-30-6 | |
| MLN0128 | 1224844-38-5 | |
| IMR-1A | 331862-41-0 | |
| PF-04691502 | 1013101-36-4 | |
| GlyH-101 | 328541-79-3 | |
| Icotinib | 610798-31-7 | |
| AG 1406 | 71308-34-4 | |
| Oglufanide | 38101-59-6 | |
| CNX-2006 | 1375465-09-0 | |
| Cediranib dihydrochloride | 288383-20-0 | |
| AZD9291DA | 1421372-66-8 | |
| Mutant EGFR inhibitor | 1421373-62-7 | |
| Mubritinib | 366017-09-6 | |
| Regorafenib Hydrochloride | 835621-07-3 | |
| Rostafuroxin | 156722-18-8 | |
| Semaxinib | 204005-46-9 | |
| SU 5205 | 3476-86-6 | |
| JK-P3 | 942655-44-9 | |
| KNK437 | 218924-25-5 | |
| SU5408 | 15966-93-5 | |
| Fruquintinib | 1194506-26-7 | |
| Brivanib alaninate | 649735-63-7 | |
| Tivozanib | 475108-18-0 | |
| Lavendustin A | 125697-92-9 | |
| N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide | 439081-18-2 | |
| Regorafenib monohydrate | 1019206-88-2 | |
| Lusutrombopag | 1110766-97-6 | |
| Vatalanib | 212141-54-3 | |
| AC-55541 | 916170-19-9 | |
| Copanlisib | 1032568-63-0 | |
| XL147 | 956958-53-5 | |
| 3-Methyladenine | 5142-23-4 | |
| GDC0941 | 957054-30-7 | |
| PIK 75 hydrochloride | 372196-77-5 | |
| AZD8186 | 1627494-13-6 | |
| LY-900009 | 209984-68-9 | |
| XL 765 | 1349796-36-6 | |
| Umbralisib | 1532533-67-7 | |
| VPS34-IN1 | 1383716-33-3 | |
| AS-604850 | 648449-76-7 | |
| Rigosertib sodium | 1225497-78-8 | |
| Preladenant | 377727-87-2 | |
| CPI-444 | 1202402-40-1 | |
| HMN-214 | 173529-46-9 | |
| GSK-461364 | 929095-18-1 | |
| Obatoclax mesylate | 803712-79-0 | |
| CID5721353 | 301356-95-6 | |
| Elafibranor | 923978-27-2 | |
| GW 627368X | 439288-66-1 | |
| Palosuran | 540769-28-6 | |
| 17-Phenyl Trinor Prostaglandin F2α Methyl Amide | 155206-01-2 | |
| PD123319 | 130663-39-7 | |
| WAY-100635 maleate | 634908-75-1 | |
| Eltoprazine hydrochloride | 98206-09-8 | |
| Cloprostenol sodium | 55028-72-3 | |
| E7046 | 1369489-71-3 | |
| ETP-46321 | 1252594-99-2 | |
| MDK34597 | 371934-59-7 | |
| Pilaralisib | 934526-89-3 | |
| GSK-3787 | 188591-46-0 | |
| EPZ015666 | 1616391-65-1 | |
| Cediranib maleate | 857036-77-2 | |
| AZ5104 | 1421373-98-9 | |
| Methyl 2,5-dihydroxycinnamate | 63177-57-1 | |
| AZD-8931 | 848942-61-0 | |
| UNC-0638 | 1255580-76-7 | |
| Icotinib hydrochloride | 1204313-51-8 | |
| Zibotentan | 186497-07-4 | |
| Irbinitinib | 937263-43-9 | |
| IOX2 | 931398-72-0 | |
| AG-1557 | 189290-58-2 | |
| EGF816 | 1508250-71-2 | |
| EPZ015866 | 1616391-87-7 | |
| Darusentan | 171714-84-4 | |
| SU 4942 | 76086-99-2 | |
| hVEGF-IN-1 | 1637443-98-1 | |
| AV-412 | 451492-95-8 | |
| WZ-4002 | 1213269-23-8 | |
| Naquotinib | 1448232-80-1 | |
| 3-Methyltoxoflavin | 32502-62-8 | |
| MS023 | 1831110-54-3 | |
| MSDC-0602 | 1133819-87-0 | |
| UNC1215 | 1415800-43-9 | |
| EAI045 | 1942114-09-1 | |
| Brivanib | 649735-46-6 | |
| CL-387785 | 194423-06-8 |
联系方式
电话：-+1-631-485-4226
邮箱：inquiry@bocsci.com
网址： https://www.bocsci.com/
产品总数： 19552
地址：
CB指数：58
国籍：美国
